Status:
UNKNOWN
Vitamin D and Inflammatory Markers of Cardiovascular Disease in African Americans With Type 2 Diabetes
Lead Sponsor:
Cook County Health
Collaborating Sponsors:
Rush University
Conditions:
Vitamin D Deficiency
Diabetes
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Recent clinical trials in non diabetics showed that vitamin D supplementation markedly reduced serum levels of C-reactive protein (CRP), interleukin-6, and tissue matrix metallo-proteinases. Our study...
Detailed Description
Other questions in our study: In diabetic African American patients, 1. Prevalence of vitamin D deficiency? 2. Correlation/relationship between vitamin D levels, Calcium level, parathyroid hormone (P...
Eligibility Criteria
Inclusion
- African Americans
- DM type 2
Exclusion
- symptomatic vitamin D deficiency
- hypocalcemia
- hypercalcemia
- malabsorption
- liver disease
- patients with creatinine \> 1.5. (CKD \>/= 3)
- pregnancy
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
117 Patients enrolled
Trial Details
Trial ID
NCT01153243
Start Date
April 1 2007
End Date
June 1 2011
Last Update
April 7 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.